<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Clin Nucl Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">Clin Nucl Med</journal-id>
      <journal-id journal-id-type="publisher-id">RLU</journal-id>
      <journal-title-group>
        <journal-title>Clinical Nuclear Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0363-9762</issn>
      <issn pub-type="epub">1536-0229</issn>
      <publisher>
        <publisher-name>Lippincott</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24458180</article-id>
      <article-id pub-id-type="pmc">3969153</article-id>
      <article-id pub-id-type="publisher-id">RLU13614</article-id>
      <article-id pub-id-type="doi">10.1097/RLU.0000000000000356</article-id>
      <article-id pub-id-type="art-access-id">00017</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Interesting Images</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Conjunctival MALT Lymphoma</article-title>
        <subtitle>Utility of FDG PET/CT for Diagnosis, Staging, and Evaluation of Treatment Response</subtitle>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Sallak</surname>
            <given-names>Asmaa</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Besson</surname>
            <given-names>Florent L.</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pomoni</surname>
            <given-names>Anastasia</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Christinat</surname>
            <given-names>Alexandre</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="aff1">&#x2020;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Adler</surname>
            <given-names>Marcel</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="aff1">&#x2020;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Aegerter</surname>
            <given-names>Jean-Philippe</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="aff1">&#x2021;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nguyen</surname>
            <given-names>Christophe</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="aff1">&#xA7;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Leval</surname>
            <given-names>Laurence</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="aff1">&#xB6;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Frossard</surname>
            <given-names>Val&#xE9;rie</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="aff1">&#x2225;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Prior</surname>
            <given-names>John O.</given-names>
          </name>
          <degrees>PhD, MD</degrees>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">From the Departments of *Nuclear Medicine, &#x2020;Oncology, and &#x2021;Hematology, Lausanne University Hospital; &#xA7;Jules Gonin Eye Hospital; &#xB6;Department of Pathology, Lausanne University Hospital, Lausanne; and &#x2225;Department of Oncology, Sion Hospital, Sion, Switzerland.</aff>
      <author-notes>
        <corresp>Reprints: John O. Prior, PhD, MD, Department of Nuclear Medicine, Lausanne University Hospital, Rue du Bugnon 46, CH-1011 Lausanne, Switzerland. E-mail: <email>john.prior@chuv.ch</email>.</corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>3</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>31</day>
        <month>1</month>
        <year>2014</year>
      </pub-date>
      <volume>39</volume>
      <issue>3</issue>
      <fpage>295</fpage>
      <lpage>297</lpage>
      <history>
        <date date-type="received">
          <day>8</day>
          <month>7</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>11</day>
          <month>12</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2014 by Lippincott Williams &amp; Wilkins</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license>
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License, where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially. <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0">http://creativecommons.org/licenses/by-nc-nd/3.0</ext-link>.</license-p>
        </license>
      </permissions>
      <self-uri xlink:type="simple" xlink:href="rlu-39-295.pdf"/>
      <abstract>
        <title>Abstract</title>
        <p>A 67-year-old woman was referred for staging of a mucosa-associated lymphoid tumor lymphoma involving the left conjunctiva. CT scan had shown paravertebral and pelvic masses, and a breast nodule. FDG PET/CT demonstrated moderately increased uptake in the left ocular conjunctiva and confirmed the paravertebral and pelvic masses and the breast nodule. Moreover, abnormal FDG uptake was shown in 2 breast nodules, the flank, the gluteus maximus, and the gastric cardia. The patient received 6 cycles of rituximab-bendamustine chemotherapy with a complete clinical and metabolic response at the 6-month follow-up PET/CT and remained relapse-free without visual acuity problem after a 36-month follow-up.</p>
      </abstract>
      <kwd-group>
        <title>Key Words</title>
        <kwd><sup>18</sup>F</kwd>
        <kwd>FDG</kwd>
        <kwd>PET</kwd>
        <kwd>ocular lymphoma</kwd>
        <kwd>MALT</kwd>
        <kwd>ocular adnexal MALT lymphoma</kwd>
        <kwd>conjunctival MALT lymphoma</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>OPEN-ACCESS</meta-name>
          <meta-value>TRUE</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <fig id="FU1" position="float">
      <label>FIGURE 1</label>
      <caption>
        <p><bold>A</bold>, Baseline FDG PET/CT showing increased glucose analog in the left conjunctiva (arrow) as compared with the contralateral side (left-to-right SUV ratio, 3.0). <bold>B</bold>, Control after 3 of 6 cycles of chemotherapy showing an excellent metabolic response with normalized left-to-right SUV ratio to 1.0 (arrowhead).</p>
      </caption>
      <graphic xlink:href="rlu-39-295-g001"/>
    </fig>
    <fig id="FU2" position="float">
      <label>FIGURE 2</label>
      <caption>
        <p><bold>A</bold>, Maximal intensity projection image of the baseline FDG PET showing extraocular lesions with increased pathologic uptake situated in the right paravertebral mass (*), 3 left breast nodules (arrowhead), the gastric cardia (arrow), the left flank (f), the left gluteus maximus muscle (m), and a pelvic paramedian right mass (p). <bold>B</bold>, The same maximal intensity projection image after 3 cycles of chemotherapy showing disappearance of all abnormal FDG uptake sites. The final diagnosis made on a biopsy of the left conjunctiva was a marginal zone lymphoma of mucosa-associated lymphoid tumor (MALT) type (stage III EA). Extranodal marginal zone lymphoma of MALT type is a relatively rare type of B-cell lymphoma accounting for 7% to 8% of non-Hodgkin lymphomas.<xref rid="R1" ref-type="bibr">1</xref> They arise in the stomach, bowel, lung, ocular adnexa, breast, thyroid, skin, soft tissue, and dura, predominantly in patients older than 60 years.<xref rid="R2" ref-type="bibr">2</xref> FDG PET/CT has now become part of the diagnostic workup of patients with lymphoma. It is known as being more sensitive than CT for extranodal lesions usually upstaging the disease extent. PET is also now playing a role in the follow-up of lymphoma and during the chemotherapy to assess initial response and determine prognosis. It is known that the conjunctiva is one of the main sites of ocular lymphoma and that lymphomas of conjunctival origin can be detected by FDG PET/CT.<xref rid="R3" ref-type="bibr">3</xref>&#x2013;<xref rid="R5" ref-type="bibr">5</xref> Likewise, tumoral lesions of the bulbar conjunctiva of other origin can also be seen by FDG PET/CT.<xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R7" ref-type="bibr">7</xref> In the largest up-to-date reported use of PET/CT in ocular adnexal lymphomas, Zanni et al<xref rid="R8" ref-type="bibr">8</xref> reported 32% of conjunctival lymphomas with FDG PET positivity in only 35% of the cases. In view of the high sensitivity of conventional imaging (CT/MRI) to detect conjunctival involvement, FDG PET does not seem to be particularly useful for establishing the initial diagnosis, besides helping to choose the biopsy site. However, FDG PET can be recommended for staging patients with ocular adnexal lymphomas because of the high frequency of extraocular tumoral sites that can be multiple as in the case of our patient.<xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R8" ref-type="bibr">8</xref> FDG uptake is known to be lower or negative in MALT lymphomas, although this has not been confirmed in ocular adnexal lymphomas.<xref rid="R5" ref-type="bibr">5</xref> Nevertheless, scintigraphy with somatostatin receptor analogs could be useful in selected cases.<xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R10" ref-type="bibr">10</xref> Indeed, the visualization of a unique lesion directly influences the treatment strategy (surgery, radiation therapy) as compared with a disseminated disease (systemic therapy such as single-agent or combination chemotherapy, immunotherapy with rituximab, monoclonal chimeric anti-CD20 antibodies, or radioimmunotherapy with <sup>90</sup>Y ibritumomab tiuxetan [Zevalin]; recently antichlamydial antibiotics therapy have also been proposed as an alternative).<xref rid="R9" ref-type="bibr">9</xref> The prognosis of MALT lymphoma of conjunctival origin is excellent, and the transformation into a high-grade lymphoma is exceptional.</p>
      </caption>
      <graphic xlink:href="rlu-39-295-g002"/>
    </fig>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>Conflicts of interest and sources of funding: none declared.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="R1">
        <label>1.</label>
        <mixed-citation publication-type="journal">
<person-group><name><surname>Anderson</surname><given-names>JR</given-names></name><name><surname>Armitage</surname><given-names>JO</given-names></name><name><surname>Weisenburger</surname><given-names>DD</given-names></name></person-group>
<article-title>Epidemiology of the non-Hodgkin&#x2019;s lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin&#x2019;s Lymphoma Classification Project</article-title>.
<source><italic>Ann Oncol</italic></source>. 
<year>1998</year>;
<volume>9</volume>:
<fpage>717</fpage>&#x2013;
<lpage>720</lpage><pub-id pub-id-type="pmid">9739436</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2.</label>
        <mixed-citation publication-type="journal">
<person-group><name><surname>Thomas</surname><given-names>AG</given-names></name><name><surname>Vaidhyanath</surname><given-names>R</given-names></name><name><surname>Kirke</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Extranodal lymphoma from head to toe: part 1, the head and spine</article-title>.
<source><italic>AJR Am J Roentgenol</italic></source>. 
<year>2011</year>;
<volume>197</volume>:
<fpage>350</fpage>&#x2013;
<lpage>356</lpage><pub-id pub-id-type="pmid">21785080</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3.</label>
        <mixed-citation publication-type="journal">
<person-group><name><surname>Matsuo</surname><given-names>T</given-names></name><name><surname>Ichimura</surname><given-names>K</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Conjunctival lymphoma can be detected by FDG PET</article-title>.
<source><italic>Clin Nucl Med</italic></source>. 
<year>2012</year>;
<volume>37</volume>:
<fpage>516</fpage>&#x2013;
<lpage>519</lpage><pub-id pub-id-type="pmid">22475910</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4.</label>
        <mixed-citation publication-type="journal">
<person-group><name><surname>Hayashi</surname><given-names>D</given-names></name><name><surname>Devenney-Cakir</surname><given-names>B</given-names></name><name><surname>Lee</surname><given-names>JC</given-names></name><etal/></person-group>
<article-title>Mucosa-associated lymphoid tissue lymphoma: multimodality imaging and histopathologic correlation</article-title>.
<source><italic>AJR Am J Roentgenol</italic></source>. 
<year>2010</year>;
<volume>195</volume>:
<fpage>W105</fpage>&#x2013;
<lpage>W117</lpage><pub-id pub-id-type="pmid">20651169</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5.</label>
        <mixed-citation publication-type="journal">
<person-group><name><surname>Gayed</surname><given-names>I</given-names></name><name><surname>Eskandari</surname><given-names>MF</given-names></name><name><surname>McLaughlin</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Value of positron emission tomography in staging ocular adnexal lymphomas and evaluating their response to therapy</article-title>.
<source><italic>Ophthalmic Surg Lasers Imaging</italic></source>. 
<year>2007</year>;
<volume>38</volume>:
<fpage>319</fpage>&#x2013;
<lpage>325</lpage><pub-id pub-id-type="pmid">17674923</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6.</label>
        <mixed-citation publication-type="journal">
<person-group><name><surname>Abdelmalik</surname><given-names>AG</given-names></name><name><surname>Fajnwaks</surname><given-names>P</given-names></name><name><surname>Osman</surname><given-names>MM</given-names></name><etal/></person-group>
<article-title>Squamous cell carcinoma of the bulbar conjunctiva seen on F-18 FDG PET/CT</article-title>.
<source><italic>Clin Nucl Med</italic></source>. 
<year>2010</year>;
<volume>35</volume>:
<fpage>962</fpage>&#x2013;
<lpage>964</lpage><pub-id pub-id-type="pmid">21206233</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7.</label>
        <mixed-citation publication-type="journal">
<person-group><name><surname>Lin</surname><given-names>LF</given-names></name><name><surname>Chang</surname><given-names>CY</given-names></name><name><surname>Cherng</surname><given-names>SC</given-names></name></person-group>
<article-title>Advanced squamous cell carcinoma of the bulbar conjunctiva seen on PET/CT</article-title>.
<source><italic>Clin Nucl Med</italic></source>. 
<year>2008</year>;
<volume>33</volume>:
<fpage>929</fpage>&#x2013;
<lpage>930</lpage><pub-id pub-id-type="pmid">19033813</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8.</label>
        <mixed-citation publication-type="journal">
<person-group><name><surname>Zanni</surname><given-names>M</given-names></name><name><surname>Moulin-Romsee</surname><given-names>G</given-names></name><name><surname>Servois</surname><given-names>V</given-names></name><etal/></person-group>
<article-title>Value of <sup>18</sup>FDG PET scan in staging of ocular adnexal lymphomas: a large single-center experience</article-title>.
<source><italic>Hematology</italic></source>. 
<year>2012</year>;
<volume>17</volume>:
<fpage>76</fpage>&#x2013;
<lpage>84</lpage><pub-id pub-id-type="pmid">22664045</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9.</label>
        <mixed-citation publication-type="journal">
<person-group><name><surname>Stefanovic</surname><given-names>A</given-names></name><name><surname>Lossos</surname><given-names>IS</given-names></name></person-group>
<article-title>Extranodal marginal zone lymphoma of the ocular adnexa</article-title>.
<source><italic>Blood</italic></source>. 
<year>2009</year>;
<volume>114</volume>:
<fpage>501</fpage>&#x2013;
<lpage>510</lpage><pub-id pub-id-type="pmid">19372259</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10.</label>
        <mixed-citation publication-type="journal">
<person-group><name><surname>Dabbagh Kakhki</surname><given-names>VR</given-names></name></person-group>
<article-title><sup>18</sup>F-FDG-PET, gallium-67 and somatostatin receptor scintigraphy, in ocular MALT lymphoma</article-title>.
<source><italic>Hell J Nucl Med</italic></source>. 
<year>2008</year>;
<volume>11</volume>:
<fpage>49</fpage>; <comment>author reply 50</comment><pub-id pub-id-type="pmid">18392230</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
